Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRX-7EAT in shoulder tendonitis and bursitis
NCT01161615Phase 3Completed
- Sponsor
- MEDRx
- Start
- Jul 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in shoulder bursitis comparing MRX-7EAT with Placebo (2 arms). Primary endpoint: Mean of Current Pain Intensity scores. Started Jul 2010; status: completed.
02
Drugs
etodolac + lidocaine
03
Conditions
shoulder bursitis
Beyond the preview
Go deeper on NCT01161615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01161615.